Proarrhythmic potential of reverse use-dependent drugs.
Gussak
Ihor
I
eResearch Technology, Inc, Philadelphia, PA, USA. igussak@ert.com <igussak@ert.com>
Litwin
Jeffrey
J
Morganroth
Joel
J
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D015764:Bepridil / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D026902:Potassium Channel Blockers / Q000009:adverse effects*; D018570:Risk Assessment; D012307:Risk Factors
D000889:Anti-Arrhythmia Agents; D026902:Potassium Channel Blockers; D015764:Bepridil